Lawver Teri L insider trades
Lawver Teri L has filed 8 Form 4s with the SEC that we hold, for Altimmune, Inc. (ALT) (Director), Dexcom INC (DXCM) (EVP Chief Commercial Officer) and Celldex Therapeutics, Inc. (CLDX) (SVP & Chief Commercial Officer). Across all of them we count 0 purchases worth $0 and 1 sale worth $640.3K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 4,764 shares of Dexcom INC worth $640.3K, dated 2024-03-12. The first filing on our record is dated 2023-03-10 and the latest 2026-06-29.
Altimmune, Inc. (ALT)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Dexcom INC (DXCM)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-03-12 | S, sale reported on Form 4 | 4,764 | $640.3K | 2024-03-14 |
Celldex Therapeutics, Inc. (CLDX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1960596) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms